How much did Switchpoint Bio raise?

Switchpoint Bio raised $5.3M at Pre-Seed, announced 11 November 2026.

Who founded Switchpoint Bio?

Samuel Myllykangas is Co-Founder & CEO of Switchpoint Bio.

What does Switchpoint Bio do?

Switchpoint Bio operates in HealthTech and is based in Finland.

FundedStartupsDaily / HealthTech / Switchpoint Bio

Switchpoint Bio raises $5.3M

Switchpoint Bio announced a Pre-Seed round of $5.3M on 11 November 2026. The company operates in HealthTech and is based in Finland. It was founded by Samuel Myllykangas, Co-Founder & CEO. Announced yesterday.

Raised

$5.3M

Stage

Pre-Seed

Industry

HealthTech

Country

Finland

Founder

Samuel Myllykangas

Co-Founder & CEO, Switchpoint Bio

LinkedIn not available

Outreach angles

-Samuel Myllykangas previously built and scaled Blueprint Genetics, which Quest Diagnostics acquired in 2020.
-Myllykangas co-founded Switchpoint Bio with Jason Buenrostro, inventor of ATAC-seq, after they developed targeted sequencing technologies together at Stanford.
-Switchpoint Bio emerged from stealth with a $5.3M pre-seed round including $5M from Treehouse Delmar Investments to read drug response from blood epigenomics.